$14.910
+1.806 (+12.11%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
ADARx Pharmaceuticals, Inc. (ADRX) Moving Averages Convergence Divergence (MACD) indicator is -1.24, suggesting ADRX is Sell.
ADARx Pharmaceuticals, Inc. (ADRX) 20-Day simple moving average is 16.15, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $—, making it Sell.
ADARx Pharmaceuticals, Inc. (ADRX) 60-Day simple moving average is 17.20, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $—, making it Sell.
Technical Analysis for ADRX
AI Technical ADRXAs of 2026-11-07, the technical board for ADARx Pharmaceuticals, Inc. (ADRX) reads sell: 2 indicators are flashing buy, 7 are indicating sell, and 4 are neutral. Price at $14.91 sits below the 20-day, 60-day and 200-day moving averages and above the 5-day and 10-day.
Momentum readings: RSI stands at 44.137, MACD stands at -1.241 (Sell), Stochastic %K stands at 21.719, Stochastic %D stands at 17.71 and CCI stands at -64.245.
ADRX trades below the 60-day SMA (17.20) and below the 200-day SMA (17.20). Immediate resistance sits at Classic R1 17.62, then R2 20.66. Support sits at Classic S1 12.02, then S2 9.46.
ADARx Pharmaceuticals, Inc. (ADRX) Support & Resistance Level
ADARx Pharmaceuticals, Inc. (ADRX) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 44.137 |
| STOCHk_14_3_3 | 21.719 |
| STOCHd_14_3_3 | 17.710 |
| CCI_20 | -64.245 |
| AO_5_34 | -3.613 |
| MOM_10 | -2.940 |
| MACD_12_26_9 | -1.241 |
ADARx Pharmaceuticals, Inc. (ADRX) Relative Strength Index (RSI_14) is 44.137, creating a Neutral signal.
ADARx Pharmaceuticals, Inc. (ADRX) Stochastic %K is 21.719, creating a Neutral signal.
ADARx Pharmaceuticals, Inc. (ADRX) Stochastic %D is 17.710, creating a Buy signal.
ADARx Pharmaceuticals, Inc. (ADRX) CCI_20 is -64.245, creating a Neutral signal.
ADARx Pharmaceuticals, Inc. (ADRX) Awesome Oscillator (AO) is -3.613, creating a Sell signal.
ADARx Pharmaceuticals, Inc. (ADRX) Momentum (MOM) is -2.940, creating a Sell signal.
ADARx Pharmaceuticals, Inc. (ADRX) Moving Average Convergence Divergence (MACD) is -1.241, creating a Sell signal.
ADARx Pharmaceuticals, Inc. (ADRX) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 13.746 | Buy |
| MA_10 | 14.583 | Buy |
| MA_20 | 16.148 | Sell |
| MA_60 | 17.205 | Sell |
| MA_200 | 17.205 | Sell |
| MA_250 | 17.205 | Sell |
ADARx Pharmaceuticals, Inc. (ADRX) 5-Day simple moving average is 13.746, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Buy.
ADARx Pharmaceuticals, Inc. (ADRX) 10-Day simple moving average is 14.583, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Buy.
ADARx Pharmaceuticals, Inc. (ADRX) 20-Day simple moving average is 16.148, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Sell.
ADARx Pharmaceuticals, Inc. (ADRX) 60-Day simple moving average is 17.205, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Sell.
ADARx Pharmaceuticals, Inc. (ADRX) 200-Day simple moving average is 17.205, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Sell.
ADARx Pharmaceuticals, Inc. (ADRX) 250-Day simple moving average is 17.205, while ADARx Pharmaceuticals, Inc. (ADRX) share price is $, making it a Sell.
Related articles
- International Stocks vs US Stocks in 2026: How the Strong Dollar and Valuations Change the CaseInternational stocks vs US stocks in 2026: how the strong dollar, valuation gaps, Fed hikes and concentration risk shape a smarter global allocation plan now.
- Defensive Stocks in 2026: Is the Rush Into Staples and Healthcare Already Overcrowded?Investors are piling into defensive stocks as tech slides. See why staples and healthcare surged, why valuations look stretched, and how to avoid overpaying.
- Defense Stocks in 2026: How Midterms, the Iran War and a Stalled Budget Shape the OutlookDefense stocks fell after the 2026 midterms. Learn how the Iran war, the $1.5T budget request and the December 11 funding deadline shape the sector outlook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.